Skip to main content

Table 1 (abstract P15). Outcome measures

From: 12th European Headache Federation Congress jointly with 32nd National Congress of the Italian Society for the Study of Headaches

Parameter Erenumab 140 mg Placebo
ETT
 Peak SBP 172.1 (22.9) 172.2 (22.4)
 Peak DBP 90.1 (15.1) 90.3 (15.4)
 Peak heart rate 122.2 (19.7) 122.6 (22.0)
Post-ETT
 SBP 134.5 (15.2) 135.0 (18.5)
 DBP 76.2 (9.3) 79.2 (11.6)
 Heart rate 73.3 (8.7) 78.8 (13.7)
  1. ETT exercise treadmill tests, DBP diastolic blood pressure, SBP systolic blood pressure